LONDON (ShareCast) - (ShareCast News) - Transatlantic healthcare intellectual property commercialisation group NetScientific announced the issue by the US Patent and Trademark Office of a new patent exclusively licensed to its portfolio company, Wanda, on Monday.
The AIM-traded company said the patent would "significantly extend" protection for the core technology used in Wanda's software application for remote health and patient management.

It said the patent, titled 'context-aware prediction in medical systems, was among the technologies developed at the University of California, Los Angeles, which aimed to "better assess and predict" medical events by defining and using contextual data on top of medical information.

"We are delighted to announce this strengthening of the IP landscape for Wanda, which represents an important step for Wanda's organisational development," said NetScientific CEO and Wanda chairman Francois Martelet.

"We believe Wanda's class leading predictive and behavioural analytics platform acts as a competitive differentiator in the emerging and highly exciting digital health sector."

NetScientific holds a 61% stake in Wanda, on a fully-diluted basis.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE